120 related articles for article (PubMed ID: 5394748)
1. Effect of terodiline on cardiac and brain catecholamines in the rat.
Bertler A; Nordgren L; Rosengren E
Acta Pharmacol Toxicol (Copenh); 1969; 27(4):314-6. PubMed ID: 5394748
[No Abstract] [Full Text] [Related]
2. Effect of beta-adrenergic blocking compounds on tissue catecholamine levels.
Klinge EA
Eur J Pharmacol; 1971 Apr; 14(2):124-9. PubMed ID: 4151170
[No Abstract] [Full Text] [Related]
3. Phenylethyldithiocarbamate: a new dopamine-beta-hydroxylase inhibitor.
Jonsson J; Grobecker H; Gunne LM
J Pharm Pharmacol; 1967 Mar; 19(3):201-3. PubMed ID: 4382347
[No Abstract] [Full Text] [Related]
4. [Effect of aminazin on the content of adrenaline, nordrenaline, dopamine and dopa in rat tissue in closed cranio-cerebral trauma].
Matlina ESh; Rakhmanova TB
Farmakol Toksikol; 1969; 32(2):138-40. PubMed ID: 5772133
[No Abstract] [Full Text] [Related]
5. Effect of instrumental heart-rate training on rat cardiac and brain catecholamines.
DiCara LV; Stone EA
Psychosom Med; 1970; 32(4):359-68. PubMed ID: 5514176
[No Abstract] [Full Text] [Related]
6. Occurrence of noradrenaline and metabolites of primary catecholamines in the brain and heart of Helix.
Osborne NN; Cottrell GA
Comp Gen Pharmacol; 1970 Mar; 1(1):1-10. PubMed ID: 5527541
[No Abstract] [Full Text] [Related]
7. Effects of amphetamine on urinary and tissue catecholamines in rats after inhibition of its metabolism with desmethylimipramine.
Lewander T
Eur J Pharmacol; 1968 Dec; 5(1):1-9. PubMed ID: 5718514
[No Abstract] [Full Text] [Related]
8. Response of neurogenic amines to aggregation and strangers.
Bliss EL; Ailion J
J Pharmacol Exp Ther; 1969 Aug; 168(2):258-63. PubMed ID: 5816819
[No Abstract] [Full Text] [Related]
9. [Effect of hydrocortisone and desoxycorticosterone on the content of catecholamines in the brain, heart and adrenal gland of rats].
Górny D
Acta Physiol Pol; 1968; 19(6):813-23. PubMed ID: 5708969
[No Abstract] [Full Text] [Related]
10. Tissue catecholamine levels in normotensive, genetically hypertensive and renal hypertensive rats.
Robertson AA; Hodge JV; Laverty R; Smirk FH
Aust J Exp Biol Med Sci; 1968 Dec; 46(6):689-96. PubMed ID: 5729724
[No Abstract] [Full Text] [Related]
11. Interaction of DOPA decarboxylase inhibitors with the effect of alpha-methyldopa on blood pressure and tissue monoamines in rats.
Henning M
Acta Pharmacol Toxicol (Copenh); 1969; 27(2):135-48. PubMed ID: 5819569
[No Abstract] [Full Text] [Related]
12. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
Mazurkiewicz-Kwilecki IM; Romagnoli A
J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
[No Abstract] [Full Text] [Related]
13. Catecholamines concentration in brain and heart tissue of rats and its blood pressure during chronic treatment with a new tricyclic antidepressant 10-(3-dimethylaminopropyl)-7-chlorobenzo-(b), (1,8)-naphthyridone-5 monohydrochloride (IF-C-45).
Filczewski M; Szymańska-Kosmala M
Pol J Pharmacol Pharm; 1975; 27(3):277-82. PubMed ID: 1144206
[TBL] [Abstract][Full Text] [Related]
14. [Influence of reserpine on the libration of catecholamines in the brain and heart of rats in ontogenetic development (author's transl)].
Swirska A; Wańkowicz B
Probl Med Wieku Rozwoj; 1975; 5():83-90. PubMed ID: 1223888
[TBL] [Abstract][Full Text] [Related]
15. The effects of peripherally administered 6-hydroxydopamine on rat brain monoamine turnover.
Clark WG; Corrodi H; Masuoka DT
Eur J Pharmacol; 1971 Jun; 15(1):41-4. PubMed ID: 5161339
[No Abstract] [Full Text] [Related]
16. Effects of 6-hydroxydopamine on putative transmitter substances in the central nervous system.
Jacks BR; de Champlain J; Cordeau JP
Eur J Pharmacol; 1972 May; 18(3):353-60. PubMed ID: 5035623
[No Abstract] [Full Text] [Related]
17. Monoiodotyrosine: effects on tissue amines and cold survival.
Auman JR; Sheffield KL; Prange AJ
Neuropsychobiology; 1976; 2(5-6):277-82. PubMed ID: 1029805
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
Lytle LD; Shoemaker WJ; Cottman K; Wurtman RJ
J Pharmacol Exp Ther; 1972 Oct; 183(1):56-64. PubMed ID: 5080034
[No Abstract] [Full Text] [Related]
19. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
Corrodi H; Fuxe K
Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
[No Abstract] [Full Text] [Related]
20. Study of a possible interference of alpha-methyl-para-tyrosine pretreatment on the radioenzymatic assay of catecholamines in the rat brain.
Tizabi Y; Massari VJ; Jacobovitz DM
J Neurochem; 1979 Oct; 33(4):959-61. PubMed ID: 385810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
